Robalzotan (NAD-299), a Novel Selective 5-Ht 1A Receptor Antagonist

CNS Drug Reviews
doi 10.1111/j.1527-3458.1999.tb00101.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Treatment of Hypertension With Ketanserin, a New Selective 5-Ht2 Receptor Antagonist.

BMJ
1982English

AE9C90CB: A Novel, Bladder-Selective Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder

British Journal of Pharmacology
Pharmacology
2010English

Pharmacological Profile of VP-343, a Novel Selective Vasopressin V2 Receptor Antagonist, in Rats.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2000English

5-Ht3 Receptor Antagonism by Anpirtoline, a Mixed 5-Ht1 Receptor Agonist/5-Ht3 Receptor Antagonist

British Journal of Pharmacology
Pharmacology
1995English

Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140)

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2019English

Characterization of Binding, Functional Activity and Contractile Responses of the Selective 5‐HT 1F Receptor Agonist Lasmiditan

British Journal of Pharmacology
Pharmacology
2019English

Effect of a Selective 5-Ht Reuptake Inhibitor in Combination With 5-HT1Aand 5-HT1Breceptor Antagonists on Extracellular 5-Ht in Rat Frontal Cortexin Vivo

British Journal of Pharmacology
Pharmacology
1997English

Anandamide, an Endogenous Cannabinoid Receptor Ligand, Also Interacts With 5-Hydroxytryptamine (5-Ht) Receptor.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1998English

Idalopirdine, a Selective 5-Ht6 Receptor Antagonist, Reduces Food Intake and Body Weight in a Model of Excessive Eating

Metabolic Brain Disease
BiochemistryMolecular NeuroscienceNeurologyCellular
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy